Question 1

Which best describes drug polymorphism?

Accepted Answer

A) Cultural and genetic effects on drug metabolism and excretion 
B) Gender and cultural effects on drug absorption and distribution 
C) Age or body composition effects on drug absorption or metabolism 
D) Multidrug use resulting in impaired excretion 
A) Cultural and genetic effects on drug metabolism and excretion 
B) Gender and cultural effects on drug absorption and distribution 
C) Age or body composition effects on drug absorption or metabolism 
D) Multidrug use resulting in impaired excretion C

Question 2

Which statement correctly describes drugs in Part G,Part II of the Food and Drugs Act?

Accepted Answer

A) They are drugs with high potential for misuse that have an accepted medical use. 
B) They are drugs with high potential for misuse that do not have an accepted medical use. 
C) They are medically accepted drugs that may cause mild physical or psychological dependence. 
D) They are medically accepted drugs with very limited potential for causing mild physical or psychological dependence. 
A) They are drugs with high potential for misuse that have an accepted medical use. 
B) They are drugs with high potential for misuse that do not have an accepted medical use. 
C) They are medically accepted drugs that may cause mild physical or psychological dependence. 
D) They are medically accepted drugs with very limited potential for causing mild physical or psychological dependence. A

Question 3

A member of an investigational drug study team is working with healthy volunteers whose participation will help determine the optimal dosage range and pharmacokinetics of the drug.In what type of study is the team member participating?

Accepted Answer

A) Phase I 
B) Phase II 
C) Phase III 
D) Phase IV 
A) Phase I 
B) Phase II 
C) Phase III 
D) Phase IV A

Question 4

A patient has a prescription for a drug classified as Schedule F.What important information should the nurse give this patient about obtaining refills for this medication?

Accepted Answer

A) No prescription refills are permitted. 
B) Refills may be obtained via telephone order. 
C) Refills are indicated by the prescriber. 
D) The patient may have no more than six refills in a 12-month period. 
A) No prescription refills are permitted. 
B) Refills may be obtained via telephone order. 
C) Refills are indicated by the prescriber. 
D) The patient may have no more than six refills in a 12-month period.

Question 5

A patient has been chosen to be a recipient of an investigational drug for heart failure and has given informed consent.Which is indicated by the patient's informed consent?

Accepted Answer

A) The patient has been informed of the possible benefits of the new therapy. 
B) The patient will be informed of the details of the study as the research continues. 
C) The patient will not be assured of receiving the actual drug during the experiment. 
D) The patient has received an explanation of the study's purpose, procedures, and the benefits and risks involved. 
A) The patient has been informed of the possible benefits of the new therapy. 
B) The patient will be informed of the details of the study as the research continues. 
C) The patient will not be assured of receiving the actual drug during the experiment. 
D) The patient has received an explanation of the study's purpose, procedures, and the benefits and risks involved.

Question 6

What potential failure is identified when a patient with a documented penicillin allergy receives 1.2 g of benzylpenicillin IV?

Accepted Answer

A) Failure to assess 
B) Failure to evaluate 
C) Failure to ensure safety 
D) Failure to identify the patient 
A) Failure to assess 
B) Failure to evaluate 
C) Failure to ensure safety 
D) Failure to identify the patient

Question 7

In the development of a new drug by a pharmaceutical company,the researcher must ensure that the participants in experimental drug studies do not have unrealistic expectations of the new drug's usefulness.What will the researcher include in the design of the study to prevent bias that may occur?

Accepted Answer

A) A placebo 
B) Health Canada approval 
C) Informed consent 
D) Efficacy information 
A) A placebo 
B) Health Canada approval 
C) Informed consent 
D) Efficacy information

Question 8

Which is the most significant part of legislation in regard to professional nursing practice?

Accepted Answer

A) Canada Health Act 
B) Nursing Practice Act 
C) Controlled Drugs and Substances Act 
D) Personal Information Protection and Electronic Documents Act 
A) Canada Health Act 
B) Nursing Practice Act 
C) Controlled Drugs and Substances Act 
D) Personal Information Protection and Electronic Documents Act

Question 9

Which contributes to drug polymorphism?

Accepted Answer

A) The number of drugs ordered by the physician 
B) The patient's drug history 
C) The patient's age, sex, and body composition 
D) Different dosage forms of the same drug 
A) The number of drugs ordered by the physician 
B) The patient's drug history 
C) The patient's age, sex, and body composition 
D) Different dosage forms of the same drug

Question 10

Which are elements of ethical principles in nursing and health care according to the Canadian Nurses Association (CNA)Code of Ethics? (Select all that apply.)

Accepted Answer

A) Promoting justice 
B) Maintaining anonymity 
C) Demonstrating responsibility 
D) Preserving dignity 
E) Promoting health and well-being 
A) Promoting justice 
B) Maintaining anonymity 
C) Demonstrating responsibility 
D) Preserving dignity 
E) Promoting health and well-being

Exam 3: Legal and Ethical Considerations

Which best describes drug polymorphism?

Which statement correctly describes drugs in Part G,Part II of the Food and Drugs Act?

A member of an investigational drug study team is working with healthy volunteers whose participation will help determine the optimal dosage range and pharmacokinetics of the drug.In what type of study is the team member participating?

A patient has a prescription for a drug classified as Schedule F.What important information should the nurse give this patient about obtaining refills for this medication?

A patient has been chosen to be a recipient of an investigational drug for heart failure and has given informed consent.Which is indicated by the patient's informed consent?

What potential failure is identified when a patient with a documented penicillin allergy receives 1.2 g of benzylpenicillin IV?

In the development of a new drug by a pharmaceutical company,the researcher must ensure that the participants in experimental drug studies do not have unrealistic expectations of the new drug's usefulness.What will the researcher include in the design of the study to prevent bias that may occur?

Which is the most significant part of legislation in regard to professional nursing practice?

Which contributes to drug polymorphism?

Which are elements of ethical principles in nursing and health care according to the Canadian Nurses Association (CNA)Code of Ethics? (Select all that apply.)

Nursing Practice in Canada and Drug Therapy

Pharmacological Principles

Patient Focused Considerations

Gene Therapy and Pharmacogenomics

Medication Errors: Preventing and Responding

Patient Education and Drug Therapy

Over-the-Counter Drugs and Natural Health Products

Vitamins and Minerals

Principles of Drug Administration

Analgesic Drugs

General and Local Anaesthetics

Central Nervous System Depressants and Muscle Relaxants

Central Nervous System Stimulants and Related Drugs

Antiepileptic Drugs

Antiparkinsonian Drugs

Psychotherapeutic Drugs

Substance Misuse

Adrenergic Drugs

Adrenergic-Blocking Drugs

Cholinergic Drugs

Cholinergic-Blocking Drugs

Antihypertensive Drugs

Antianginal Drugs

Heart Failure Drugs

Antidysrhythmic Drugs

Coagulation Modifier Drugs

Antilipemic Drugs

Diuretic Drugs

Fluids and Electrolytes

Pituitary Drugs

Thyroid and Antithyroid Drugs

Antidiabetic Drugs

Adrenal Drugs

Women’s Health Drugs

Men’s Health Drugs

Antihistamines,Decongestants,Antitussives,and Expectorants

Respiratory Drugs

Acid-Controlling Drugs

Antidiarrheal Drugs and Laxatives

Antiemetic and Anti-nausea Drugs

Nutritional Supplements

Antibiotics, Part 1: Sulfonamides, Penicillins, Cephalosporins, Macrolides, and Tetracyclines

Antibiotics Part 2: Aminoglycosides, Fluoroquinolones, and Other Drugs

Antiviral Drugs

Antitubercular Drugs

Antifungal Drugs

Antimalarial, Antiprotozoal, and Anthelmintic Drugs

Anti-Inflammatory and Antigout Drugs

Immunosuppressant Drugs

Immunizing Drugs and Pandemic Preparedness

Antineoplastic Drugs Part 1: Cancer Overview and Cell Cycle–Specific Drugs

Antineoplastic Drugs Part 2: Cell Cycle–Nonspecific and Miscellaneous Drugs

Biological Response–Modifying Drugs

Anemia Drugs

Dermatological Drugs

Ophthalmic Drugs

Otic Drugs

Filters